Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Busshoff

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Urology Focus|November 6, 2024
Prostate Biopsy: The Transrectal Approach Is SafeIsabelle Busshoff, Friederike Haidl, Jan Philipp Radtke, et al.
Urologie (Heidelberg, Germany)|March 3, 2026
[Biparametric versus multiparametric magnetic resonance imaging for the diagnosis of prostate cancer]Isabelle Busshoff, Rouvier Al-Monajjed, Matthias Boschheidgen, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2025
Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsyJale Lakes, Rouvier Al-Monajjed, Isabelle Busshoff, et al.
Urologie (Heidelberg, Germany)|May 7, 2026
[Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?]Felix Seelemeyer, Rouvier Al-Monajjed, Muammar Dib, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Urology Focus|November 6, 2024
Prostate Biopsy: The Transrectal Approach Is SafeIsabelle Busshoff, Friederike Haidl, Jan Philipp Radtke, et al.
Urologie (Heidelberg, Germany)|March 3, 2026
[Biparametric versus multiparametric magnetic resonance imaging for the diagnosis of prostate cancer]Isabelle Busshoff, Rouvier Al-Monajjed, Matthias Boschheidgen, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2025
Modern active surveillance in low- and intermediate-risk prostate cancer without re-biopsyJale Lakes, Rouvier Al-Monajjed, Isabelle Busshoff, et al.
Urologie (Heidelberg, Germany)|May 7, 2026
[Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?]Felix Seelemeyer, Rouvier Al-Monajjed, Muammar Dib, et al.
Pageof 1